Cirrhosis

Cirrhosis is a condition in which the liver slowly deteriorates and malfunctions due to chronic injury. Scar tissue replaces healthy liver tissue, partially blocking the flow of blood through the liver.
What is Cirrhosis?

Cirrhosis is a severe form of liver disease wherein normal liver tissue is replaced by scar tissue (fibrous tissue).

Read More

Overview

Latest Cirrhosis News and Research

Machine learning model to determine associations between metabolic syndrome and lactation

Machine learning model to determine associations between metabolic syndrome and lactation

Risk of non-alcoholic fatty liver disease for cardiovascular disease and all cause death in patients with type 2 diabetes mellitus

Risk of non-alcoholic fatty liver disease for cardiovascular disease and all cause death in patients with type 2 diabetes mellitus

Chula researchers develop wireless hepatitis B test kit for rapid diagnosis

Chula researchers develop wireless hepatitis B test kit for rapid diagnosis

Blood biomarkers in TGF-β pathway identify hidden liver cancer risk

Blood biomarkers in TGF-β pathway identify hidden liver cancer risk

Cirrhosis patients face mixed infection outcomes amid pandemic healthcare shifts

Cirrhosis patients face mixed infection outcomes amid pandemic healthcare shifts

Viscoelasticity emerges as key marker for liver cancer in diabetes

Viscoelasticity emerges as key marker for liver cancer in diabetes

Study: Up to 10% of dementia cases in veterans may be caused by liver disease

Study: Up to 10% of dementia cases in veterans may be caused by liver disease

NHS health checks linked to reduced risk of heart, brain, kidney, and liver diseases

NHS health checks linked to reduced risk of heart, brain, kidney, and liver diseases

Dietary carotenoids may reduce risk of non-alcoholic fatty liver disease, study suggests

Dietary carotenoids may reduce risk of non-alcoholic fatty liver disease, study suggests

3D-printed liver model paves way for new MASH treatments

3D-printed liver model paves way for new MASH treatments

Study links GLP1 agonists to reduced risk of severe liver disease in diabetic patients

Study links GLP1 agonists to reduced risk of severe liver disease in diabetic patients

NHS Health Check linked to lower disease rates and mortality, study shows

NHS Health Check linked to lower disease rates and mortality, study shows

The crucial need for ongoing COVID-19 booster vaccination in vulnerable populations

The crucial need for ongoing COVID-19 booster vaccination in vulnerable populations

TRPC3 emerges as key player in preventing damage from alcohol-associated liver disease

TRPC3 emerges as key player in preventing damage from alcohol-associated liver disease

New imaging technique could transform diagnosis and treatment of steatotic liver disease

New imaging technique could transform diagnosis and treatment of steatotic liver disease

£30M clinical study will enhance the understanding of NASH cirrhosis

£30M clinical study will enhance the understanding of NASH cirrhosis

Gut microbes revealed as key players in liver disease solutions

Gut microbes revealed as key players in liver disease solutions

Exploring the global health challenge of hepatitis D

Exploring the global health challenge of hepatitis D

Simple mail trick doubles liver cancer screening rates for high-risk patients

Simple mail trick doubles liver cancer screening rates for high-risk patients

Study shows synergistic effects of genetic factors, binge drinking, and diabetes in alcohol-related cirrhosis

Study shows synergistic effects of genetic factors, binge drinking, and diabetes in alcohol-related cirrhosis